Clinical Trial Update: Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV [Phase 4]

View source ↗

Summary

Phase 4 clinical trial analyzing viral kinetics of peginterferon alfa-2a, ribavirin, and epoetin beta in patients coinfected with HCV/HIV; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)
• epoetin beta (epoetin beta)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: HIV Infections | Phase 4 | Status: COMPLETED